This inventor holds 1 USPTO granted patent. Top assignee: Arjil Biotech Holding Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Chung-Hsin Wu in Atherosclerosis Treatment.
Introduction
Chung-Hsin Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of atherosclerosis. His innovative approach focuses on utilizing natural compounds to combat this prevalent health issue.
Latest Patents
Chung-Hsin Wu holds a patent for a method and composition aimed at reversing and/or inhibiting atherosclerosis. The patent, titled "Method and composition for reversing and/or inhibiting atherosclerosis," describes a method for alleviating atherosclerosis in a subject by administering a composition that includes Antcin K. This innovative solution highlights the potential of natural compounds in addressing serious health conditions.
Career Highlights
Chung-Hsin Wu is associated with Arjil Biotech Holding Company Limited, where he continues to develop and refine his innovative ideas. His work at the company emphasizes the importance of research and development in the biotechnology sector, particularly in creating effective treatments for cardiovascular diseases.
Conclusion
Chung-Hsin Wu's contributions to the field of atherosclerosis treatment through his innovative patent demonstrate the potential of natural compounds in medical applications. His work not only advances scientific knowledge but also offers hope for improved health outcomes in patients suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile